Abstract
Background
In pancreatic cancer, extensive tumor involvement of the mesenteric venous system
poses formidable challenges to operative resection. Such involvement can result from
cavernous collateral veins leading to increased intraoperative blood loss or long-segment
vascular defects of not only just the superior mesenteric vein but also even jejunal/ileal
branches. Strategies to facilitate margin-free resection and safe vascular reconstruction
in pancreatic surgery are important, particularly because systemic control of the
tumor is improving with multi-agent chemotherapy regimens.
Methods
We describe a systematic, multidisciplinary assessment for patients with pancreatic
cancer that involves the superior mesenteric vein, as well as the preoperative planning
of those undergoing operative resection. In addition, detailed descriptions of operative
approaches and technical strategies, which evolved with increasing experience at a
high-volume center, are presented.
Results
For the preoperative evaluation of tumor-free, vascular locations for potential reconstruction
and collateralization, computed tomographic imaging with high-resolution of vascular
structures (used with 3-dimensional or cinematic rendering) allows a precise calibration
of radiographic data with intraoperative findings. From an operative perspective,
we identified 5 potential strategies to consider for resection: collateral preservation,
mesoportal bypass (preresection), mesoportal interposition graft (postresection),
mesocaval shunt, and various combinations of these strategies. Many of these techniques
use interposition grafts, making it essential to assess autologous veins (preferred
conduit for reconstruction) or to prepare cryopreserved vascular allografts (an alternative
conduit, which must be thawed and should be matched for size and blood type).
Conclusion
Herein we share operative strategies to overcome involvement of the superior mesenteric
vein in pancreatic cancer. Improvements in preoperative planning and operative technique
can address common barriers to resection with curative intent.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Complications of pancreatic surgery.HPB. 2005; 7: 99-108
- Two thousand consecutive pancreaticoduodenectomies.J Am Coll Surg. 2015; 220: 530-536
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.Lancet. 2017; 389: 1011-1024
- FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer.N Engl J Med. 2018; 379: 2395-2406
- Pancreatic adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2017; 15: 1028-1061
- Locally advanced pancreatic cancer: neoadjuvant therapy with FOLFIRINOX results in resectability in 60% of the patients.Ann Surg. 2016; 264: 457-463
- Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection.Ann Surg. 2019; 270: 340-347
- Nomenclature of the veins of the lower limb: extensions, refinements, and clinical application.J Vasc Surg. 2005; 41: 719-724
- Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer.Br J Surg. 2017; 104: 1539-1548
- Technical risk factors for portal vein reconstruction thrombosis in pancreatic resection.J Vasc Surg. 2015; 62: 424-433
- Pancreatectomy with vein reconstruction: technique matters.HPB. 2015; 17: 824-831
- Indication for the use of an interposed graft during portal vein and/or superior mesenteric vein reconstruction in pancreatic resection based on perioperative outcomes.Langenbecks Arch Surg. 2014; 399: 461-471
- Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer.J Gastroenterol Hepatol. 2016; 31: 1498-1503
- Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.J Int Med Res. 2016; 44: 1339-1348
- Comparison of end-to-end anastomosis and interposition graft during pancreatoduodenectomy with portal vein reconstruction for pancreatic ductal adenocarcinoma.Langenbecks Arch Surg. 2019; 404: 191-201
- Comparison of patency rates and clinical impact of different reconstruction methods following portal/superior mesenteric vein resection during pancreatectomy.Pancreatology. 2016; 16: 1113-1123
- Imaging pancreatic cancer: the role of multidetector CT with three-dimensional CT angiography.Pancreatology. 2001; 1: 610-624
- Cinematic rendering of pancreatic neoplasms: preliminary observations and opportunities.Abdom Radiol N Y. 2018; 43: 3009-3015
- The “artery first” approach for resection of pancreatic head cancer.J Am Coll Surg. 2010; 210: e1-e4
- Uncinate process first—a novel approach for pancreatic head resection.Langenbecks Arch Surg. 2010; 395: 1161-1164
- Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis.J Natl Cancer Inst. 2019; 111: 782-794
- Neoadjuvant and adjuvant chemotherapy in pancreatic cancer.Langenbecks Arch Surg. 2018; 403: 917-932
- Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension.Surgery. 2014; 155: 449-456
- A new type of portal-to-systemic venous shunt for portal hypertension.Arch Surg. 1955; 71: 588
- Mesentero-caval anastomosis.J Cardiovasc Surg. 1966; 70: 70
- Mesocaval shunting: a novel technique to facilitate venous resection and reconstruction and enhance exposure of the superior mesenteric and celiac arteries during pancreaticoduodenectomy.J Am Coll Surg. 2013; 217: e17-e20
- Distal splenorenal and mesocaval shunting at the time of pancreatectomy.Surgery. 2014; 165: 298-306
- Multidisciplinary management of pancreatic cancer.Surg Oncol Clin N Am. 2013; 22: 265-287
- Parietal peritoneum as an autologous substitute for venous reconstruction in hepatopancreatobiliary surgery.Ann Surg. 2015; 262: 366-371
Article Info
Publication History
Published online: September 17, 2020
Accepted:
July 30,
2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
